comparemela.com

Latest Breaking News On - Diana monsivais - Page 1 : comparemela.com

Protein Beclin-1 Plays Key Role in Uterine Remodeling for Pregnancy

Protein Beclin-1 Plays Key Role in Uterine Remodeling for Pregnancy
miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.

Kentucky
United-states
Rama-kommagani
Sangappab-chadchan
Christinal-stallings
Xiaoming-guan
Suni-tang
Edmundb-rucker
Kelleh-moley
Pooja-popli
Diana-monsivais
Johnp-lydon

Protein Beclin-1 Key in Uterine Remodeling and Pregnancy Establishment

Protein Beclin-1 Key in Uterine Remodeling and Pregnancy Establishment
miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.

Kentucky
United-states
Christinal-stallings
Kelleh-moley
Rama-kommagani
Sangappab-chadchan
Chandni-talwar
Diana-monsivais
Xiaoming-guan
Pooja-popli
Suni-tang
Edmundb-rucker

Proteomics analysis from aggressive human cancers can help identify potential therapeutic targets

Proteomics analysis from aggressive human cancers can help identify potential therapeutic targets Researchers at Baylor College of Medicine show that analysis of the proteomics, or all the protein data, from aggressive human cancers is a useful approach to identify potential novel therapeutic targets. They report in the journal Oncogene, the identification of proteomic signatures that are associated with clinical measures of aggressive disease for each of the seven cancer types studied. Some signatures were shared between different types of cancer and included cellular pathways of altered metabolism. Importantly, experimental results provided proof-of-concept that their proteomics analysis approach is a valuable strategy to identify potential therapeutic targets.

Chad
Diana-monsivais
Emily-henderson
Study-co
Clinical-proteomic-tumor-analysis-consortium
Danl-duncan-comprehensive-cancer-center
Researchers-at-baylor-college-of-medicine
Baylor-college
Chad-creighton
Cancer-bioinformatics
Study-co-corresponding-author
Proteomics

Proteomics analysis IDs potential drug targets for aggressive cancers

Researchers at Baylor College of Medicine show that analysis of the proteomics, or all the protein data, from aggressive human cancers is a useful.

Houston
Texas
United-states
Chad
Baylor-college-of-medicine
Darshans-chandrashekar
Yiqun-zhang
Diana-monsivais
Sooryanarayana-varambally
Yasmin-vasquez
Ramyap-masand
Fengju-chen

Proteomics analysis identifies potential drug targets for aggressive human cancers

 E-Mail Researchers at Baylor College of Medicine show that analysis of the proteomics, or all the protein data, from aggressive human cancers is a useful approach to identify potential novel therapeutic targets. They report in the journal Oncogene, the identification of proteomic signatures that are associated with clinical measures of aggressive disease for each of the seven cancer types studied. Some signatures were shared between different types of cancer and included cellular pathways of altered metabolism. Importantly, experimental results provided proof-of-concept that their proteomics analysis approach is a valuable strategy to identify potential therapeutic targets. There are two notable aspects of this study. One is that we explored the proteomic landscape of cancer looking for proteins that were expressed in association with aggressive forms of cancer, said co-corresponding author Dr. Chad Creighton, professor of medicine and co-director of Cancer Bioinformatics

Houston
Texas
United-states
Chad
Baylor-college-of-medicine
Darshans-chandrashekar
Yiqun-zhang
Diana-monsivais
Sooryanarayana-varambally
Yasmin-vasquez
Ramyap-masand
Fengju-chen

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.